| Year |
Citation |
Score |
| 2019 |
Werstein B, Dunlap J, Cascio MJ, Ohgami RS, Fan G, Press R, Raess PW. Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival. The Journal of Molecular Diagnostics : Jmd. PMID 31866570 DOI: 10.1016/J.Jmoldx.2019.11.004 |
0.311 |
|
| 2019 |
Dunlap JB, Leonard J, Rosenberg M, Cook R, Press R, Fan G, Raess P, Druker BJ, Traer E. The combination of NPM1, DNMT3A and IDH1/2 mutations leads to inferior overall survival in AML. American Journal of Hematology. PMID 31145495 DOI: 10.1002/Ajh.25517 |
0.375 |
|
| 2018 |
Werstein B, Dunlap J, Cascio M, Ohgami R, Fan G, Press R, Raess P. 325 Myeloid Sarcomas and Concurrent Bone Marrow Biopsies May Demonstrate Discordant Mutational Profiles by Massively Parallel Sequencing American Journal of Clinical Pathology. 149: S140-S140. DOI: 10.1093/Ajcp/Aqx127.324 |
0.315 |
|
| 2017 |
Ma J, Dunlap J, Paliga A, Traer E, Press R, Shen L, Fan G. DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML. Leukemia & Lymphoma. 1-11. PMID 29165010 DOI: 10.1080/10428194.2017.1397659 |
0.371 |
|
| 2016 |
Raess PW, Cascio MJ, Fan G, Press R, Druker BJ, Brewer D, Spurgeon SE. Concurrent STAT3, DNMT3A and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential. American Journal of Hematology. PMID 27761930 DOI: 10.1002/Ajh.24586 |
0.317 |
|
| 2016 |
Wiedmeier JE, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, Mori M, Druker B, Dao KH. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Experimental Hematology. PMID 27235757 DOI: 10.1016/J.Exphem.2016.05.009 |
0.364 |
|
| 2016 |
Reinig E, Yang F, Traer E, Arora R, Brown S, Rattray R, Braziel R, Fan G, Press R, Dunlap J. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. American Journal of Clinical Pathology. PMID 27124934 DOI: 10.1093/Ajcp/Aqw016 |
0.329 |
|
| 2015 |
Shi M, Spurgeon S, Press R, Olson S, Fan G. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting. Annals of Hematology. 94: 1941-4. PMID 26231802 DOI: 10.1007/S00277-015-2460-6 |
0.339 |
|
| 2013 |
Ang D, Fan G, Traer E, Kovacsovics T, Leeborg N, Loriaux M, Warrick A, Beadling C, Olson S, Gatter K, Braziel RM, Corless CL, Press R, Dunlap J. Utility of Multiplex Mutation Analysis in the Diagnosis of Chronic Myelomonocytic Leukemia Journal of Leukemia. 1: 1-6. DOI: 10.4172/2329-6917.1000114 |
0.36 |
|
| 2012 |
Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia. Human Pathology. 43: 2167-76. PMID 22658276 DOI: 10.1016/J.Humpath.2012.03.002 |
0.367 |
|
| 2011 |
Dunlap J, Kelemen K, Leeborg N, Braziel R, Olson S, Press R, Huang J, Gatter K, Loriaux M, Fan G. Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. American Journal of Clinical Pathology. 135: 709-19. PMID 21502425 DOI: 10.1309/Ajcps6C8Evycqnrm |
0.315 |
|
| 2009 |
Jones D, Kamel-Reid S, Bahler D, Dong H, Elenitoba-Johnson K, Press R, Quigley N, Rothberg P, Sabath D, Viswanatha D, Weck K, Zehnder J. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics : Jmd. 11: 4-11. PMID 19095773 DOI: 10.2353/Jmoldx.2009.080095 |
0.362 |
|
| 2007 |
Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, Mauro M, Heinrich MC, Press RD, Druker BJ, Deininger MW. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Leukemia. 21: 489-93. PMID 17252009 DOI: 10.1038/Sj.Leu.2404554 |
0.365 |
|
| 2004 |
Crossman L, Heinrich M, Press R, Willis S, Deininger M, Druker B. Various Mechanisms Underlie Cytogenetic Refractoriness to Imatinib. Blood. 104: 2091-2091. DOI: 10.1182/Blood.V104.11.2091.2091 |
0.357 |
|
| 1990 |
Press RD, Jacobberger JW, Samols D, Goldthwait D. The cell cycle dependence of c-sis gene expression: artifactual conclusions in cells prepared by chemical but not physical techniques. Cell and Tissue Kinetics. 23: 299-312. PMID 2117995 DOI: 10.1111/J.1365-2184.1990.Tb01126.X |
0.57 |
|
| 1989 |
Press RD, Misra A, Samols D, Goldthwait DA, Mapstone TB. Major structural alterations of the c-sis gene are not observed in a series of tumors of the human central nervous system. Journal of Neuro-Oncology. 7: 345-56. PMID 2585029 DOI: 10.1007/Bf02147092 |
0.565 |
|
| 1988 |
Press RD, Samols D, Goldthwait DA. Expression and stability of c-sis mRNA in human glioblastoma cells. Biochemistry. 27: 5736-41. PMID 3052584 DOI: 10.1021/Bi00415A051 |
0.565 |
|
| Show low-probability matches. |